In recent years, doctors have discovered and refined a number of innovative uses for robotics in the medical profession. However, critics are wondering if the techniques are being used too frequently as simpler and more affordable options are sometimes overlooked. Dr. David Samadi, renowned prostate cancer specialist and robotics advocate, recently defended the merits of the advanced technology.
Samadi readily admitted that patient-level marketing surrounding robotic surgery is at an all-time high. However, this is a necessary function for recouping the significant overhead costs associated with implementing the technology in medical practices. According to the Corpus Christi Caller, some devices can cost as much as $2 million to deploy. But when used properly, the benefits are undeniable.
Using the technology, Samadi has transformed prostate cancer into a highly treatable disease. After completing more than 3,500 robotic prostatectomy procedures, the doctor has attained a cancer-curing rate of approximately 97 percent. The minimally-invasive robotic procedure limits blood loss, improves a surgeon's visibility and reduces patient rehabilitation times.
There can be an overwhelming amount of information available, but in the end Samadi acknowledged that medical decisions should rest solely with patients and their families. After thoroughly investigating all options, they should ultimately settle upon a procedure and practitioner they are comfortable with.